<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Cancer Foundation For The World</title>
	<atom:link href="http://www.thecancerfoundationfortheworld.org/site/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thecancerfoundationfortheworld.org/site</link>
	<description>Cancer Sucks, We Can Make a Difference, The Anwser for Cancer</description>
	<lastBuildDate>Fri, 03 Sep 2010 22:00:05 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-4/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-4/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 22:00:05 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-4/</guid>
		<description><![CDATA[Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;<br />
<a href="http://mnt.to/f/3JbG" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-3/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-3/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 21:00:06 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-3/</guid>
		<description><![CDATA[Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;<br />
<a href="http://mnt.to/f/3JbG" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-2/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-2/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 20:00:05 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-2/</guid>
		<description><![CDATA[Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;<br />
<a href="http://mnt.to/f/3JbG" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 19:00:10 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system/</guid>
		<description><![CDATA[Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Accuray Incorporated (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family&#8230;<br />
<a href="http://mnt.to/f/3JbG" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/cancer-center-to-be-the-first-in-europe-to-install-a-cyberknife-vsi-system-the-latest-generation-of-the-cyberknife-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Agensys, An Affiliate Of Astellas, Announces Initiation Of Phase I Clinical Trial Of AGS-16M8F For Renal Cancer</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer-2/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer-2/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 18:00:08 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer-2/</guid>
		<description><![CDATA[Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in [...]]]></description>
			<content:encoded><![CDATA[<p>Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing&#8230;<br />
<a href="http://mnt.to/f/3Jbd" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Agensys, An Affiliate Of Astellas, Announces Initiation Of Phase I Clinical Trial Of AGS-16M8F For Renal Cancer</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 17:00:30 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer/</guid>
		<description><![CDATA[Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in [...]]]></description>
			<content:encoded><![CDATA[<p>Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing&#8230;<br />
<a href="http://mnt.to/f/3Jbd" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/agensys-an-affiliate-of-astellas-announces-initiation-of-phase-i-clinical-trial-of-ags-16m8f-for-renal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Open House At Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® To Community</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/open-house-at-gulf-coast-cancer-treatment-center-introduces-elekta-synergy%c2%ae-to-community/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/open-house-at-gulf-coast-cancer-treatment-center-introduces-elekta-synergy%c2%ae-to-community/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 16:00:24 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/open-house-at-gulf-coast-cancer-treatment-center-introduces-elekta-synergy%c2%ae-to-community/</guid>
		<description><![CDATA[Gulf Coast Cancer Treatment Center, the area&#8217;s only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system.  The new technology will be showcased at the center&#8217;s Open House on Thursday, September 16, 2010 from 1 p.m. to 7 p.m.  Gulf Coast Cancer Treatment Center (GCCTC) is located at 2100 State [...]]]></description>
			<content:encoded><![CDATA[<p>Gulf Coast Cancer Treatment Center, the area&#8217;s only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system.  The new technology will be showcased at the center&#8217;s Open House on Thursday, September 16, 2010 from 1 p.m. to 7 p.m.  Gulf Coast Cancer Treatment Center (GCCTC) is located at 2100 State Avenue in Panama City.  Radiation oncologists Dr. D.B&#8230;<br />
<a href="http://mnt.to/f/3Jbt" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/open-house-at-gulf-coast-cancer-treatment-center-introduces-elekta-synergy%c2%ae-to-community/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis-2/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis-2/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 15:00:35 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis-2/</guid>
		<description><![CDATA[Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps&#8230;<br />
<a href="http://mnt.to/f/3Jb2" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 14:00:04 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis/</guid>
		<description><![CDATA[Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps&#8230;<br />
<a href="http://mnt.to/f/3Jb2" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/european-collaborative-research-to-develop-lab-on-chip-system-for-cheap-and-fast-cancer-diagnosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanobiotechnology To Fight Cancer And Other Illnesses</title>
		<link>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/nanobiotechnology-to-fight-cancer-and-other-illnesses/</link>
		<comments>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/nanobiotechnology-to-fight-cancer-and-other-illnesses/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 13:00:04 +0000</pubDate>
		<dc:creator>Jeff Daas</dc:creator>
				<category><![CDATA[Latest News]]></category>

		<guid isPermaLink="false">http://www.thecancerfoundationfortheworld.org/site/2010/09/03/nanobiotechnology-to-fight-cancer-and-other-illnesses/</guid>
		<description><![CDATA[Two new groundbreaking scientific papers by researchers at UC Santa Barbara demonstrate the synthesis of nanosize biological particles with the potential to fight cancer and other illnesses. The studies introduce new approaches that are considered &#8220;green&#8221; nanobiotechnology because they use no artificial compounds&#8230;
Read Full Article
]]></description>
			<content:encoded><![CDATA[<p>Two new groundbreaking scientific papers by researchers at UC Santa Barbara demonstrate the synthesis of nanosize biological particles with the potential to fight cancer and other illnesses. The studies introduce new approaches that are considered &#8220;green&#8221; nanobiotechnology because they use no artificial compounds&#8230;<br />
<a href="http://mnt.to/f/3J8R" target="_blank"><strong>Read Full Article</strong></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.thecancerfoundationfortheworld.org/site/2010/09/03/nanobiotechnology-to-fight-cancer-and-other-illnesses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
